Moderate riskFDA DrugClass II

Alvogen Thyro-Tabs levothyroxine 150mcg recalled for wrong strength tablets in bottle

One bottle of Alvogen Thyro-Tabs 150mcg levothyroxine tablets (Lot MHA21825) was found to contain 88mcg tablets instead of the labeled 150mcg strength. This mix-up affects only a single bottle distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have Lot MHA21825 (expires December 31, 2027) of Alvogen Thyro-Tabs 150mcg
  2. Contact your pharmacy or doctor if you have this lot—do not stop taking your medication without guidance
  3. Your pharmacist can verify the tablet strength and provide correct medication if needed

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Illnesses reported
None reported
Manufactured in
44 Whippany Rd Ste 300, Morristown, NJ, United States
Classification
Class II
Recall number
D-0259-2026

In the FDA's words

Description
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10. Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets. Lot # MHA21825, Exp Date: December 31, 2027 Distribution: US Nationwide.
Hazard
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Related topics

Label mix upPotencyDrugsSold nationwideMore from FDA Drug